GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 358.37
-6.27 (-1.72%)
At close: May 11, 2026
GlaxoSmithKline Pakistan Market Cap
GlaxoSmithKline Pakistan has a market cap or net worth of 114.13 billion as of May 11, 2026. Its market cap has decreased by -19.37% in one year.
Market Cap
114.13B
Enterprise Value
104.57B
Revenue
67.35B
Ranking
n/a
PE Ratio
10.86
Stock Price
358.37
Market Cap Chart
Since September 26, 1994, GlaxoSmithKline Pakistan's market cap has increased from 3.77B to 114.13B, an increase of 2,926.62%. That is a compound annual growth rate of 11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 116.13B | -6.45% |
| Dec 31, 2025 | 124.13B | -1.80% |
| Dec 31, 2024 | 126.40B | 378.26% |
| Dec 29, 2023 | 26.43B | -5.45% |
| Dec 30, 2022 | 27.95B | -35.70% |
| Dec 31, 2021 | 43.47B | -28.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott Laboratories (Pakistan) | 89.87B |
| The Searle Company | 54.95B |
| AGP Limited | 52.75B |
| Highnoon Laboratories | 51.82B |
| Citi Pharma | 18.42B |
| Ferozsons Laboratories | 17.43B |
| Macter International | 12.73B |
| Otsuka Pakistan | 3.60B |